GlassScriptPhysician profile
Harish R Chandra
NPI 1720079247
$13,048.70
in general payments reported to CMS, 2019-2025
46 companies · $776 in 2025
The $776 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,238 · 2020: $704 · 2021: $1,451 · 2022: $2,621 · 2023: $1,427 · 2024: $831 · 2025: $776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,034.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,758.35 | 2019-2022 | |
| Abbott Laboratories | $2,467.85 | 2019-2025 | Mitraclip, Diamondback Peripheral, Confirm Rx |
| Cardiovascular Systems INC. | $1,302.53 | 2019-2021 | |
| Medtronic, INC. | $711.83 | 2021-2025 | In.Pact Admiral, Closurefast |
| Novartis Pharmaceuticals Corporation | $624.77 | 2019-2025 | |
| Boston Scientific Corporation | $545.14 | 2019-2025 | Watchman Access System |
| Amgen INC. | $338.80 | 2019-2025 | Repatha, Repatha |
| Irhythm Technologies, INC. | $291.04 | 2021-2023 | Zio Xt Patch |
| W. L. Gore & Associates, INC. | $268.06 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $267.93 | 2021-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $238.75 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $194.89 | 2022-2023 | Verquvo |
| Medicomp INC | $170.80 | 2022-2024 | Telepatch Cardiac Monitor |
| Medtronic Vascular, INC. | $170.76 | 2019 | |
| Pfizer INC. | $165.10 | 2021-2025 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harish Chandra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.